Latest News about VRTX
Recent news which mentions VRTX
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
November 12, 2023
From Motley Fool
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
From Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
From Motley Fool
4 First-in-Their-Class Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 11, 2023
From Motley Fool
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
From InvestorPlace
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
November 09, 2023
From Motley Fool
4 Reasons to Worry About Vertex Pharmaceuticals -- Debunked
November 08, 2023
Tickers
VRTX
From Motley Fool
What 10 Analyst Ratings Have To Say About Vertex Pharmaceuticals
November 07, 2023
Tickers
VRTX
From Benzinga
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
November 07, 2023
From Benzinga
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
November 07, 2023
Tickers
VRTX
From Motley Fool
Earnings Scheduled For November 6, 2023
November 06, 2023
From Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
November 06, 2023
From Benzinga
S&P 500 futures show stocks extending latest rally
November 06, 2023
From MarketWatch
7 Tech Stocks to Buy and Hold for the Next 25 Years
November 05, 2023
From InvestorPlace
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
From Benzinga
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
From Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
From Motley Fool
Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
November 01, 2023
From MarketWatch
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
November 01, 2023
Tickers
VRTX
From Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
From Motley Fool
From Motley Fool
From InvestorPlace
Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches
October 27, 2023
From Benzinga
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
October 27, 2023
From Motley Fool
2 Healthcare Stocks That Could Make You Richer
October 27, 2023
From Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
October 26, 2023
From Motley Fool
From Motley Fool
2 Best Healthcare Stocks to Buy Right Now
October 26, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.